Volume 11 Supplement 1

5th International Conference on cGMP: Generators, Effectors and Therapeutic Implications

Open Access

Study on the involvement of soluble guanylyl cyclase and its different isoforms in carbon monoxide and carbon monoxide releasing molecule-2 induced vasodilatation

  • Kelly Decaluwé1Email author,
  • Bart Pauwels1,
  • Sara Verpoest1,
  • Robrecht Thoonen2, 3,
  • Emmanuel Buys4,
  • Peter Brouckaert2, 3 and
  • Johan Van de Voorde1
BMC Pharmacology201111(Suppl 1):P20


Published: 1 August 2011


Besides nitric oxide, carbon monoxide (CO) also activates soluble guanylyl cyclase (sGC). CO as well as the CO-donor CORM-2 have been shown to possess vasodilatory properties. Whether these vasodilatory properties by CO can be attributed to sGC activation is still a matter of debate. The aim of this study was to examine the involvement of sGC and its different subunits in CO and CORM-2 induced vasodilatation within different vascular tissues.

Materials and methods

Isometric tension recordings were performed using mice isolated aortic rings, femoral artery ring segments as well as corpora cavernosa (CC). To be able to distinguish between the different sGC subunits we evaluated responses to saturated CO solutions and CORM-2 in both sGCa1-/- and sGCβ1KI/KI mice and their wild-type controls.


Saturated CO solution was unable to relax mice isolated blood vessels, whereas it induced concentration-dependent relaxations in mice CC. In CC of wild-type mice, the response to CO was completely inhibited by the sGC inhibitor ODQ. The involvement of sGC in the CO-induced corporal relaxation was further confirmed by the loss of response to CO in CC isolated from sGCβ1KI/KI mice. Moreover, the vasodilatory responses of CO in the corporal tissue of sGCa1-/- mice were strongly inhibited although not completely abolished. In contrast to CO, CORM-2 was able to relax all vascular tissues examined in the present study, although ODQ only partially blocked the response to CORM-2 in the aorta. Interestingly ODQ did not affect the CORM-2 induced relaxation in the femoral arteries and the CC, indicating that sGC is not involved, which was confirmed using the transgenic mice.


This study clearly illustrates that the molecular mechanism of CORM-2 induced vasorelaxation differs from that of CO induced vasorelaxation. While the CO induced vasorelaxation depends on activation of sGC, primarily the sGCa1β1 heterodimer, the vasorelaxing properties of CORM-2 are only partially dependent or even completely independent upon sGC activation. The observation that CO is more effective in relaxing CC tissues than other cardiovascular tissues investigated in the present study suggests that the heme-oxygenase/CO pathway may present a potential new target for therapeutic approaches towards erectile dysfunction.

Authors’ Affiliations

Department of Pharmacology, Ghent University
Department for Molecular Biomedical Research
Department of Biomedical Biology, Ghent University
Anesthesia Center for Critical Care Research, Department of Anesthesia and Critical Care, Massachusetts General Hospital, Harvard Medical School


© Decaluwé et al; licensee BioMed Central Ltd. 2011

This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.